This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
Brighthouse Financial (BHF) Soars 27.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Brighthouse Financial (BHF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
BHFPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
FinWise Bancorp (FINW) Soars 9.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
FinWise Bancorp (FINW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
FINWPositive Net Change CFRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
GrafTech (EAF) Stock Jumps 6.0%: Will It Continue to Soar?
by Zacks Equity Research
GrafTech (EAF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
EAFNegative Net Change KALUNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Centrus Energy (LEU): Can Its 12.1% Jump Turn into More Strength?
by Zacks Equity Research
Centrus Energy (LEU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
LEUPositive Net Change UAMYPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Idaho Strategic Resources (IDR) Moves 6.0% Higher: Will This Strength Last?
by Zacks Equity Research
Idaho Strategic Resources (IDR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
IDRPositive Net Change AUNegative Net Change GDXJPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Endeavour Silver (EXK) Surges 9.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Endeavour Silver (EXK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
EXKPositive Net Change HLPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Coeur Mining (CDE): Can Its 7.0% Jump Turn into More Strength?
by Zacks Equity Research
Coeur Mining (CDE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
CDEPositive Net Change UAMYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
908 Devices (MASS) Surges 7.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
908 Devices (MASS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
MASSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Mesa Labs (MLAB) Stock Jumps 5.7%: Will It Continue to Soar?
by Zacks Equity Research
Mesa Labs (MLAB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MLABPositive Net Change WATPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Aquestive Therapeutics (AQST) Soars 14.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Aquestive Therapeutics (AQST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
AQSTPositive Net Change USNAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today